US EditionPublished • loading... • Updated
MAZ-Mediated Ubiquitin-Conjugating Enzyme E2C Upregulation Promotes Breast Cancer Progression via the MAPK Signaling Pathway
Summary by Stemwell Science News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
MAZ-Mediated Ubiquitin-Conjugating Enzyme E2C Upregulation Promotes Breast Cancer Progression via the MAPK Signaling Pathway
Researchers demonstrated that Ubiquitin-conjugating enzyme E2C (UBE2C) is significantly upregulated in breast cancer and promotes its malignant progression. [Translational Oncology] Full Article
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
